FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in North America

Biotech startups in North America

Updated 16 Nov 2026

Reset
Biotech startups in North America
One-time CSV
  • 4,998 funded companies, 4,034 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~north-america.csv4,998 rows × 18 columns
CompanyCityLast roundAmountDate
Insilico MedicineCambridgeSeries E$123.0M2025-03-13
SocureIncline VillageSeries E$156.0M2026-08-27
PathosNew YorkSeries E$237.0M2026-10-23
Tiny HealthAustinSeries B$33.0M2026-09-29
Colossal BiosciencesAustinSeries C$60.0M2026-02-03
Multiply LabsSan FranciscoSeries B$75.0M2026-10-06
CraifIrvineSeries D$24.4M2026-08-18
Chai DiscoverySan FranciscoSeries C$400.0M2026-07-14

8 rows of the CSV in 5 of its 18 columns.

startups-biotech~north-america-contacts.csvUp to 2 verified founders or CEOs per company × 7 columns
CompanyPersonTitleVerified emailLinkedIn
Prime Movers LabA••• K•••General Partner & Chief Investment Officer - Satori Neuroa•••@primemoverslab.comIn the CSV
AVLabB••• B•••Founder, Managing Partnerb•••@analyticsventures.comIn the CSV
Eugit Therapeutics, IncG••• A•••General Partnerg•••@ycombinator.comIn the CSV

3 verified founder and CEO contact rows from organizations on this list, names and emails masked.

4,998
Startups
$180.7B
Total raised
648
Funded in the last 12 months
$18.0B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 4,998
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego, United States Series A $6.0M 2026-11-03 $35.0M Liquid 2 Ventures, Global Brain Corporation, BlueYard Capital +2 11 to 50 2022
Specific Biologics Specific Biologics develops gene editing technologies to treat diseases at the genetic level inside the body. Biotech Toronto, Canada Series A $35.0M 2026-11-02 $36.3M Creative Destruction Lab, Lumira Ventures, adMare Bio Innovations 1 to 10 2017
Opentrons Unicorn Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. Artificial intelligence Long Island City, United States Series E $40.0M 2026-10-29 $300.2M Y Combinator, SOSV, Khosla Ventures +2 251 to 500 2014
Pathos Pathos is a biotechnology company that uses AI to speed up oncology drug development. Artificial intelligence New York, United States Series E $237.0M 2026-10-23 $684.0M New Enterprise Associates, Lightbank, Builders VC +1 11 to 50 2022
Probably Genetic Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. Artificial intelligence San Francisco, United States Series A $12.0M 2026-10-15 $22.9M Y Combinator, Khosla Ventures, TenOneTen Ventures +2 11 to 50 2018
Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville, United States Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
Welltory Welltory produces AI-powered wellness apps for digital health tracking. Artificial intelligence Redwood City, United States Seed $2.0M 2026-10-08 $16.3M Goodwater Capital, JOINT JOURNEY, CABRA VC 51 to 100 2016
Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence San Francisco, United States Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
Biotia Biotia is a health tech startup that offers AI solutions to diagnose and control infectious diseases. Artificial intelligence Long Island City, United States Series A $9.0M 2026-10-01 $19.7M Everywhere Ventures, Sand Hill Angels, Tau Ventures +2 11 to 50 2016
ai3Bio ai3Bio develops cancer treatments for patients. Biotech Pittsburgh, United States Series A $48.0M 2026-09-29 $103.0M UPMC Enterprises 11 to 50 2019
Tiny Health Tiny Health offers at-home microbiome testing and health insights for babies, children, adults, and pregnant people. Biotech Austin, United States Series B $33.0M 2026-09-29 $46.0M TheVentureCity, Next Coast Ventures, Spero Ventures +2 11 to 50 2020
Arkea Bio Arkea Bio develops technology that reduces greenhouse gas emissions from agriculture. Biotech Charlestown, United States Series A $15.0M 2026-09-29 $60.5M Breakthrough Energy Ventures, Overview, Rabo Ventures 11 to 50 2021
BigHat Biosciences BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. Artificial intelligence San Mateo, United States Series C $75.0M 2026-09-24 $174.3M Andreessen Horowitz, Gaingels, 8VC +2 51 to 100 2019
Ramona Ramona develops high-throughput microscopy tools for biology labs. Artificial intelligence Durham, United States Series A $25.0M 2026-09-22 $59.7M National Science Foundation, National Institutes of Health, E14 Fund +1 11 to 50 2017
Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle, United States Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
ImpriMed ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. Artificial intelligence Palo Alto, United States Series A $10.0M 2026-09-18 $44.7M Plug and Play, Pear VC, Draper Associates +1 51 to 100 2017
Altis Labs Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. Artificial intelligence Toronto, Canada Series A $25.0M 2026-09-17 $31.0M Creative Destruction Lab, Debiopharm Innovation Fund, Benchstrength 11 to 50 2019
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco, United States Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012
Evia Bio Evia Bio develops non-DMSO cryopreservation solutions for life sciences. Biotech Minneapolis, United States Series A $5.5M 2026-09-16 $5.7M Newchip Accelerator, Pleasant Bay Capital Partners, Walleye Tank 1 to 10 2019
Evvy Evvy offers an AI-driven precision medicine platform focused on women's health. Artificial intelligence New York, United States Series B $40.0M 2026-09-15 $59.0M General Catalyst, BoxGroup, Left Lane Capital +2 11 to 50 2021
Mithrl Mithrl is a software development company that builds custom NGS data workflows on demand. Artificial intelligence San Francisco, United States Series A $20.0M 2026-09-15 $24.0M Bonfire Ventures 51 to 100 2023
heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York, United States Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
PGxAI PGxAI provides a clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence. Artificial intelligence Palo Alto, United States Seed $3.0M 2026-09-14 $5.0M ATEM Capital Fund LP 11 to 50 2023
Alzheon Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. Biotech Framingham, United States Series F $78.8M 2026-09-10 $343.3M Ally Bridge Group, National Institute on Aging 11 to 50 2013
TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Palo Alto, United States Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
Navion Neurosciences Navion Neurosciences develops sodium channel therapeutics for neurological diseases at a pre-clinical stage. Artificial intelligence Charlottesville, United States Seed $10.8M 2026-09-09 $21.2M Virginia Innovation Partnership Corporation, 3B Future Health Fund, UVA Licensing & Ventures Group +1 1 to 10 2021
Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco, United States Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
Cloverleaf Bio Cloverleaf Bio develops an RNA therapeutic platform for oncology. Biotech New Haven, United States Seed $33.0M 2026-09-08 $33.0M Mission BioCapital 1 to 10 2023
INIA Biosciences INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. Biotech Boston, United States Seed $1.5M 2026-09-08 $1.5M MassChallenge, MedTech Innovator 1 to 10 2020

Table 1. Biotech startups in North America: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 4,998.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco, United States Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
2 Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego, United States Series E $277.0M 2026-06-09 $678.0M RA Capital Management, Fidelity, Wellington Management +2 251 to 500 2017
3 Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego, United States Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
4 Pathos Pathos is a biotechnology company that uses AI to speed up oncology drug development. Artificial intelligence New York, United States Series E $237.0M 2026-10-23 $684.0M New Enterprise Associates, Lightbank, Builders VC +1 11 to 50 2022
5 Socure Unicorn Socure provides digital identity verification, fraud prevention, and regulatory compliance software. Artificial intelligence Incline Village, United States Series E $156.0M 2026-08-27 $900.4M Accel, Citi Ventures, JP Morgan +1 501 to 1,000 2012
6 Angitia Biopharmaceuticals Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. Biotech Westlake Village, United States Series D $130.0M 2026-02-05 $406.0M Legend Capital, OrbiMed, Oriza Holdings +1 51 to 100 2018
7 Diagonal Therapeutics Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. Biotech Watertown, United States Series B $125.0M 2026-01-08 $253.0M Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 11 to 50 2022
8 Claris Biotherapeutics Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. Biotech Jersey City, United States Series B $118.0M 2026-07-28 $225.1M RA Capital Management, Novo Holdings, Janus Henderson Investors +1 1 to 10 2018
9 Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego, United States Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
10 Bridge to Life Bridge to Life develops organ preservation and perfusion solutions for transplant centers and procurement organizations. Biotech Northbrook, United States Series C $110.0M 2026-08-12 $167.5M Perceptive Advisors 101 to 250 2005

Table 2. Biotech startups in North America: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Y Combinator Startup accelerator Mountain View, United States 70 1% 14 Opentrons, Probably Genetic, Multiply Labs
2 National Science Foundation Entrepreneurship program Alexandria, United States 49 1% 10 Ramona, Talus Bio, Remedium Bio
3 Alumni Ventures Angel group Manchester, United States 37 1% 6 Century Health, ParcelBio, Modicus Prime
4 SOSV Venture capital firm Princeton, United States 36 1% 13 Opentrons, Prolific Machines, heXem bio
5 RA Capital Management Startup incubator Boston, United States 32 1% 6 Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics
6 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 31 1% 12 Prolific Machines, heXem bio, BryoSphere
7 Alexandria Venture Investments Venture capital firm Pasadena, United States 27 1% 5 TwoStep Therapeutics, Lycia Therapeutics, Triveni Bio
8 OrbiMed Private equity firm New York, United States 25 1% 6 Triveni Bio, Terremoto Biosciences, Angitia Biopharmaceuticals
9 Techstars Startup accelerator New York, United States 22 0% 2 Kimba, Modicus Prime
10 Khosla Ventures Venture capital firm Menlo Park, United States 20 0% 7 Opentrons, Probably Genetic, Moonwalk Biosciences
11 Andreessen Horowitz Venture capital firm Menlo Park, United States 20 0% 1 BigHat Biosciences
12 National Institutes of Health Entrepreneurship program Bethesda, United States 20 0% 4 Ramona, Talus Bio, Terrestrial Bio
13 ARCH Venture Partners Venture capital firm Chicago, United States 20 0% 2 Moonwalk Biosciences, Mirador Therapeutics
14 Plug and Play Startup accelerator Sunnyvale, United States 20 0% 6 ImpriMed, Prellis Biologics, WittGen Biotechnologies
15 MassChallenge Startup accelerator Boston, United States 19 0% 4 INIA Biosciences, Condor Software, NANOCHON

Table 3. Biotech startups in North America: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 4,033 81% $160.6B
Software 862 17% $29.0B
Artificial intelligence 543 11% $21.3B
Hardware 185 4% $5.4B
Energy 58 1% $1.1B
Fintech 53 1% $2.0B
Cybersecurity 52 1% $1.7B
Commerce 32 1% $299.1M
Education 30 1% $158.3M

Table 4. Biotech startups in North America by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 489 10% $275K
Seed 2,104 42% $906K
Series A 1,108 22% $15.0M
Series B 701 14% $26.0M
Series C 351 7% $31.0M
Series D+ 245 5% $40.0M

Table 5. Biotech startups in North America by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 4,686 94%
Canada 285 6%
Mexico 27 1%

Table 6. Biotech startups in North America by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 396 8%
Cambridge 272 5%
New York 263 5%
San Diego 231 5%
Boston 211 4%
Palo Alto 87 2%
Seattle 86 2%
Toronto 77 2%
South San Francisco 69 1%
Houston 61 1%
Berkeley 57 1%
Los Angeles 56 1%

Table 7. Biotech startups in North America by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 10 2% $241.8M
October 2026 51 8% $1.7B
September 2026 76 12% $2.2B
August 2026 54 8% $1.5B
July 2026 48 7% $1.0B
June 2026 60 9% $2.2B
May 2026 56 9% $860.2M
April 2026 42 6% $929.4M
March 2026 52 8% $1.0B
February 2026 41 6% $983.2M
January 2026 78 12% $2.9B
December 2025 60 9% $1.6B
November 2025 20 3% $697.5M

Table 8. Biotech startups in North America: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 568 11% $15.7B
2025 537 11% $14.5B
2024 421 8% $12.3B
2023 385 8% $8.5B
2022 413 8% $9.1B
2021 432 9% $15.0B

Table 9. Biotech startups in North America by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 652 13%
2020 to 2022 833 17%
2015 to 2019 1,498 31%
2010 to 2014 900 18%
Before 2010 1,027 21%

Table 10. Biotech startups in North America by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 2,248 47%
11 to 50 1,905 39%
51 to 100 380 8%
101 to 250 169 3%
251 to 500 48 1%
501 to 1,000 41 1%
1,001 to 5,000 14 0%
5,001 to 10,000 8 0%
10,001 or more 20 0%

Table 11. Biotech startups in North America by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in North America are on the list?
4,998, in the file dated 16 November 2026. 648 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 4,998 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in North America: 4,998 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in North America by funding stage

Other sectors in North America

Biotech startups elsewhere

Cite: FundingWatcher, 4,998 funded biotech companies in North America, 16 November 2026. https://fundingwatcher.com/startups/biotech/north-america/